Participated · Seed · Apr 2024

XUND develops MDR-certified SaMD products and an internal large language model called RAVE to support digital interactions from prevention through diagnosis. Its solutions are already used by insurers, hospitals, and pharmaceutical companies as the first digital point of contact. The company employs more than 40 people across Vienna, Budapest, and London. Founded in 2018, XUND positions itself as a European homegrown champion in AI-powered healthcare infrastructure. With a recent €6 million pre-Series A raise, it is pursuing accelerated expansion in DACH and the UK and plans deeper integration of its medical devices with RAVE. The firm emphasizes building a data-driven, personalised healthcare system and aligning with EU initiatives around AI investment and technological sovereignty. XUND builds an AI-powered health assistant and four medical modules to digitise the entire patient lifecycle, enabling digital interactions from prevention to diagnosis and monitoring. Its platform uses proprietary NLP models that analyse millions of medical publications and is considered a class IIa medical device under the EU MDR. The company’s B2B customers include health insurers, healthcare providers, pharmaceutical companies, pharmacies and digital health firms. XUND plans to develop Medical Large Language Models (MedLLMs) in partnership with Thieme Group, using Thieme’s medical content combined with XUND’s NLP technology to deliver personalised medical content. The initial joint prototype with Thieme will be showcased at DMEA. XUND raised an additional €2M in a seed extension, bringing total funding to €8M to support product development and growth. XUND uses AI to analyse and process millions of medical publications and offers a medically approved/certified API that customers can use as a baseline for digital symptom assessment and patient navigation. The platform combines symptoms, personal risk factors, and demographic data to help users understand their symptoms, receive reliable assessments of possible causes, and take appropriate next steps. CEO and co-founder Tamás Petrovics says the company aims to cover the entire patient lifecycle from prevention through diagnosis, treatment, and monitoring. XUND positions itself as an infrastructure provider for digital patient interactions across insurance, pharma, digital and in-person healthcare. Financially, the company recently closed a €6 million seed round — described as one of Austria’s largest seed rounds to date. The new capital will be used to expand operations beyond the DACH region into additional European markets and to enter the U.S. market.

Participated · Seed · Feb 2019

8sense is an e-health startup based in Rosenheim, Germany that provides a virtual back coach combining a sensor and a mobile app. The company primarily acts as a system provider (B2B) while also selling coaching systems direct to end customers (B2C). It was co-founded by Ralf Seeland and Christoph Tischner. 8sense raised a €1M seed financing; backers included High‑Tech Gründerfonds, Thieme Group and a business angel from the BayStartUp network. The company said it will use the funds to maintain growth. The product focuses on sensor-driven mobile coaching for back health.

Participated · Equity · Jan 2017

LifeTime (a brand of connected-health.eu GmbH) offers an encrypted mobile app that lets users store and share medical files — reports, x-rays and lab results — secured by PIN or fingerprint. The company also supplies LifeTime Hub, a small hardware device for doctors’ offices and hospitals to facilitate sharing patient reports. Led by founder & CEO Johannes Jacubeit, LifeTime positions itself in the connected-health space in Hamburg, Germany. The company closed an interim financing round totaling over €1m. It intends to use the proceeds to grow its product offering and to increase sales in Hamburg and the surrounding regions. Operating details such as revenue or user counts were not disclosed in the article.

Participated · Equity · Jan 2017

Connected Health is a Hamburg-based MedTech startup that developed the LifeTime system — a patient-facing LifeTime App and a hardware LifeTime Hub for medical institutions. The system enables a paperless method of exchanging medical documents and images between physicians and patients. A distinguishing feature is that patients' data remains exclusively on their smartphones rather than being stored in a cloud. The company says the system aims to replace non-digital, analogue processes within medical practices and to lead the medical industry into the digital age. Connected Health was founded at the end of 2014 by Dr. Johannes Jacubeit and IT specialist Matthias Lau. After securing the latest interim financing, the company is currently capitalized at a value of more than €3 million.